The Bioinformatician Bottleneck: Why Core Facilities Need Analysis Partners
Core facilities generate more data than ever but often lack the bioinformatics capacity to analyze it. How external analysis partnerships solve this bottleneck without building an in-house team.
Modern core facilities generate more data than ever — but an increasing amount of that data never becomes publications.
A flow cytometry core can process hundreds of samples per week. A genomics core can turn around RNA-seq in days. A spatial biology core running GeoMx or Visium produces datasets with thousands of spatial measurements per experiment. The instruments are running. The data is flowing. But the bottleneck is no longer data generation — it’s data analysis.
The Gap
Most core facilities are staffed and funded to operate instruments, optimize protocols, and deliver raw data or basic QC reports. What they’re typically not staffed for is the downstream bioinformatics that turns raw data into biological insight:
- Differential expression analysis with proper statistical design
- Spatial deconvolution and compartment-specific profiling
- Multi-omics integration (RNA + protein concordance)
- Pathway enrichment and functional interpretation
- Publication-quality figures and comprehensive analysis reports
- Custom analysis pipelines for non-standard experimental designs
Some large academic institutions have centralized bioinformatics cores, but these are often oversubscribed — with wait times measured in months, not days. Smaller institutions may have no bioinformatics support at all.
The result: researchers receive their data and then struggle to analyze it themselves, cobbling together tutorials, ChatGPT prompts, and half-understood R scripts. Or worse, the data sits on a hard drive for months while the PI searches for a collaborator or postdoc who “knows bioinformatics.”
The consequences are not just inconvenience:
- Delayed publications — data that could support a paper sits unanalyzed for months
- Frustrated users — researchers who can’t get analysis support look for other cores or platforms
- Reduced repeat business — if generating data doesn’t lead to results, PIs stop submitting samples
- Underutilized instruments — high demand for data generation, low throughput on the analysis side
Why Hiring Doesn’t Always Work
The obvious solution — hire a bioinformatician — sounds straightforward but is surprisingly difficult:
Salary competition: A competent bioinformatician commands $80K-$120K+ in the academic market, more in industry. Core facilities operating on instrument fee revenue often can’t compete.
Breadth of expertise: A single hire needs to cover flow cytometry analysis, RNA-seq, spatial transcriptomics, proteomics, and whatever new platform the core acquires next year. That’s an unrealistic expectation for one person.
Utilization: The demand for bioinformatics is project-driven and bursty. A core might need intense analysis support for two months, then nothing for three months, then a flood of projects. A full-time hire is either overwhelmed or underutilized.
Retention: Skilled bioinformaticians are in high demand. Academic positions compete with industry salaries, startup opportunities, and remote consulting roles. Turnover is a constant challenge.
The Partnership Model
An alternative to permanent headcount is a bioinformatics analysis partner — an external team that provides on-demand analysis capacity, scales with project volume, and brings breadth of expertise across platforms and analysis types.
Unlike general bioinformatics consultants, an effective analysis partner for core facilities must understand instrument-specific data formats, work within core timelines (days to weeks, not months), and deliver publication-ready outputs that PIs can use directly. This model works well because:
Flexible Capacity
Analysis support scales with demand. During busy periods, the partner handles the overflow. During quiet periods, there’s no salary obligation. This converts a fixed cost (FTE salary + benefits + overhead) into a variable cost aligned with revenue.
Cross-Platform Expertise
A bioinformatics consulting team analyzes data from many platforms and many study designs. They’ve seen the edge cases, the failed QC scenarios, the unusual experimental designs. This breadth of experience is difficult to replicate with a single in-house hire.
Faster Turnaround
A dedicated analysis partner can start on a project within days, not months. There’s no queue behind other institutional projects, no teaching or committee obligations pulling the analyst away.
Continuity
If an in-house bioinformatician leaves, institutional knowledge walks out the door — including undocumented analysis pipelines, custom scripts, and project history. An external partner maintains continuity across staff transitions.
Cores that don’t solve the analysis bottleneck risk becoming data-generation services rather than research enablers. Data that isn’t analyzed doesn’t just sit idle — it erodes trust in the core.
What Good Analysis Support Looks Like
Not all bioinformatics support is created equal. Here’s what core facility managers should look for:
1. They understand your instruments. If your core runs GeoMx DSP, your analysis partner should know GeoMx data formats, QC metrics, normalization options, and the specific analytical challenges of spatial ROI-based data. Generic “we analyze any data” claims are a red flag.
2. They deliver reports, not scripts. Researchers and PIs need interpreted results — figures with legends, statistical summaries with context, methods sections ready for manuscripts. Raw R output is not a deliverable.
3. They communicate in biology, not code. The best bioinformaticians translate between computational methods and biological meaning. “We ran DESeq2 with a batch-corrected design formula and identified 342 DEGs at padj < 0.05” is incomplete. “Your treatment upregulates inflammatory signaling in the tumor compartment while suppressing oxidative metabolism in the stroma” is useful.
4. They document everything. Every analysis parameter, every exclusion criterion, every normalization choice should be documented and reproducible. If a reviewer asks “why did you use Q3 normalization instead of TMM?” the answer should be in the methods, not in someone’s memory.
5. They push back when appropriate. A good analysis partner will tell you when your experimental design has problems, when your sample size is too small for the comparison you want, or when your data quality limits the conclusions you can draw. Agreement isn’t the same as expertise.
The Core Facility’s Role
The partnership works best when the core facility:
- Provides clean metadata: Sample IDs, experimental groups, batch information, and any relevant clinical or experimental annotations. Incomplete metadata is the single biggest source of delays in bioinformatics projects.
- Communicates the biological question: “Here’s the data, analyze it” is not a project brief. “We’re comparing immune infiltration in treatment vs. control tumors, stratified by tumor stage” is.
- Sets expectations on timeline and scope: A 10-sample pilot analysis and a 200-sample multi-cohort integration are fundamentally different projects. Define the scope upfront.
- Provides QC context: If certain samples had known issues during acquisition, communicate that before analysis begins. It saves time and prevents misleading results.
Making the Case to Administration
Core facility directors often need to justify the cost of external bioinformatics support. The argument is straightforward:
Revenue protection: If researchers can’t analyze the data your core produces, they stop using your core. Analysis support protects instrument utilization and fee revenue.
Publication output: Analyzed data becomes publications. Publications justify grants. Grants fund core usage. The cycle requires analysis to complete.
Cost comparison: While a single analysis project may cost several thousand dollars, the alternative — a full-time hire — includes salary, benefits, onboarding time, and the risk of underutilization during slow periods. For most cores, the per-project model is more cost-effective until analysis demand is consistently high enough to justify dedicated headcount.
Competitive advantage: Cores that offer “data generation + analysis” as a complete package attract more users than cores that deliver raw data only.
Common Concerns
“We already have access to a bioinformatics core.” Many institutions do — but these resources are often oversubscribed, generalist in scope, and not aligned with core-specific turnaround timelines. An external partner can complement internal resources by handling overflow, specialized platforms, or urgent projects.
“We prefer to keep analysis in-house.” Partnerships don’t have to replace in-house efforts. Many cores use external partners for specialized analyses (spatial deconvolution, multi-omics integration) while handling routine work internally. The partner fills gaps, not roles.
“This sounds expensive.” Compare the cost of a single analysis project against the cost of a dataset that never gets analyzed — no publication, no grant renewal, no repeat business from that PI. The most expensive analysis is the one that never happens.
How Cytogence Works with Core Facilities
At Cytogence, we partner with university core facilities, research institutes, and clinical labs to provide downstream analysis for spatial transcriptomics, flow cytometry, RNA-seq, and multi-omics data.
We’re not just analysts — we operate as an extension of your core, integrating into existing workflows, handling platform-specific data (GeoMx, flow cytometry, RNA-seq, and more), and delivering outputs aligned with publication and reviewer expectations.
Our typical engagement starts with a project consultation (free) to understand the experimental design and analysis needs. From there, we provide a defined scope of work with timeline and deliverables — no open-ended billing, no surprises. We can typically begin analysis within days of project scoping.
In one spatial core we partnered with, data generation turnaround was days, but analysis was taking months. By integrating external analysis support, they reduced turnaround dramatically and saw increased repeat usage from PIs who had previously looked elsewhere.
If your core is generating more data than your users can analyze, the bottleneck isn’t going away on its own. The question is whether you solve it proactively — or let it limit your core’s impact.
Cytogence provides on-demand bioinformatics support for core facilities and research institutions. Contact us to discuss a partnership.